Post hoc comparisons revealed that ANGPT2 (p < 0.01), PlGF (p < 0.0001), and ACE‐1 enzyme activity (p < 0.01) were higher in AD than controls and approached significance for sPDGFRβ in MCI versus controls (p = 0.06) and AD versus controls (p = 0.07). The gene discussed is ANGPT2; the disease is Alzheimer disease.